Product logins

Find logins to all Clarivate products below.


Kimon Kotronis

Director​, Technology Consulting

A medical doctor and avid technologist, Kimon has over 15 years of experience providing technology advisory and consultancy services to the Healthcare and Life Sciences industry, designing, developing and delivering technology solutions and systems to most of the top 20 Pharmaceutical companies. With a career spanning all aspects of the technology and data value chain in global life sciences companies and public and private healthcare organizations, he uniquely combines technology and digital transformation leadership through the creation of high performing Agile teams with domain knowledge and data management and governance skills.​

As a Director in the Technology Consulting team, Kimon leads architecture and development of custom solutions that leverage Clarivate data, integrating it with third party sources and customers’ own datasets to derive unique insights using intelligent visualizations, natural language processing, data analytics and AI technologies. ​

Kimon has written about and presented to international conferences on the challenges of data harmonization and digital product development for the generation of actionable insights in highly regulated environments. He has a MD from the Aristotle University of Thessaloniki, Greece, a MSc in Health Informatics from City University, London and a MBA from Bayes Business School, London. ​


arrow_forward
Get in touch with Kimon

Latest news

News April 28, 2026
Clarivate Introduces Nexus Connect, the First Institutional AI Gateway to Trusted Research and Learning

Nexus Connect provides a single, university-branded connector inside AI chat agents, giving students and researchers seamless access to scholarly resources and services. LONDON, UK — April 28, 2026: Clarivate Plc…

News April 27, 2026
Clarivate Report Reveals Top Global Trademark Portfolios

Amazon Technologies, L’Oréal, IGT and Glaxo Group / GSK among the largest trademark portfolio owners across jurisdictions London, U.K. April 27, 2026: Clarivate Plc (NYSE:CLVT), a leading global provider of…

News April 15, 2026
Clarivate to Report First Quarter 2026 Results on April 29, 2026

London, U.K., April 15, 2026 – (PR Newswire) – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the first…

Related resources

How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.
Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center